Notice of NHLBI Participation in PAR-20-039 "Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)"

Notice Number: NOT-HL-19-733

Key Dates
Release Date: November 19, 2019

Related Announcements
PAR-20-039

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in PAR-20-039, "Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)."

The following sections of PAR-20-039 have been updated to reflect the participation of NHLBI in this Funding Opportunity Announcement (FOA).

Part 1. Overview Information

Components of Participating Organizations

National Institute of General Medical Sciences (NIGMS)
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Environmental Health Sciences (NIEHS)
National Heart, Lung and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.859; 93.866; 93.853; 93.855; 93.847; 93.121; 93.173; 93.113; 93.233, 93.837, 93.838, 93.839, 93.840

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Helen Hunter Cox, M.H.S.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8163
Email: helen.cox@nih.gov

Financial/Grants Management Contact(s)

Ryan Lombardi
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0166
Email: lombardr@nhlbi.nih.gov